Placental aromatase is deficient in placental ischemia and preeclampsia

dc.date.accessioned2018-11-29T15:37:05Z
dc.date.accessioned2022-10-18T21:28:33Z
dc.date.available2018-11-29T15:37:05Z
dc.date.available2022-10-18T21:28:33Z
dc.date.created2018-11-29T15:37:05Z
dc.date.issued2015
dc.identifierhttp://hdl.handle.net/10533/228643
dc.identifier1140119
dc.identifierWOS:000362510600067
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4459999
dc.description.abstractIntroduction Preeclampsia is a maternal hypertensive disorder with uncertain etiology and a leading cause of maternal and fetal mortality worldwide, causing nearly 40% of premature births delivered before 35 weeks of gestation. The first stage of preec
dc.languageeng
dc.relationhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0139682
dc.relationhandle/10533/111556
dc.relation10.1371/journal.pone.0139682
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.titlePlacental aromatase is deficient in placental ischemia and preeclampsia
dc.typeArticulo


Este ítem pertenece a la siguiente institución